DIFFERENCES IN SPECIFICITY OF HEPARIN-DEPENDENT ANTIBODIES DEVELOPED DURING LOW-MOLECULAR-WEIGHT-HEPARIN THERAPY AND HIGHER CROSS-REACTIVITY WITH ORGARAN
C. Pouplard et al., DIFFERENCES IN SPECIFICITY OF HEPARIN-DEPENDENT ANTIBODIES DEVELOPED DURING LOW-MOLECULAR-WEIGHT-HEPARIN THERAPY AND HIGHER CROSS-REACTIVITY WITH ORGARAN, Thrombosis and haemostasis, 1997, pp. 1826-1826